Carson Advisory’s CVS Health CVS Stock Holding History

Carson Advisory’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$374K	Sell	3,617 -1,750	-33%	-$156K	0.17%	118
2026 Q1	$385K	Buy	5,367 +400	+8%	+$30.8K	0.2%	106
2025 Q4	$394K	Sell	4,967 -100	-2%	-$7.88K	0.2%	98
2025 Q3	$382K	Sell	5,067 -300	-6%	-$20.6K	0.21%	103
2025 Q2	$370K	Sell	5,367 -600	-10%	-$39.3K	0.24%	99
2025 Q1	$404K	Sell	5,967 -500	-8%	-$29.9K	0.27%	84
2024 Q4	$290K	Buy	+6,467	New	+$363K	0.2%	120
2024 Q2	–	Sell	-2,998	Closed	-$239K	–	169
2024 Q1	$239K	Sell	2,998 -93	-3%	-$7.1K	0.17%	144
2023 Q4	$244K	Sell	3,091 -1,031	-25%	-$73.4K	0.19%	131
2023 Q3	$288K	Sell	4,122 -475	-10%	-$33.7K	0.25%	107
2023 Q2	$318K	Buy	+4,597	New	+$327K	0.27%	102

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Carson Advisory's CVS Position: Q2 2026 in Review

Carson Advisory reduced its CVS Health (CVS) stake by 33% in Q2 2026, selling an estimated $156K and leaving 3,617 shares worth $374K. The position accounts for 0.17% of the portfolio, ranked #118.

Carson Advisory first reported a position in CVS in Q2 2023 and has held it in 11 quarters since. The position peaked at $404K in Q1 2025. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Carson Advisory held 3,617 shares of CVS Health worth $374K as of Q2 2026.
Carson Advisory sold 1,750 CVS Health shares in Q2 2026, an estimated $156K.
CVS Health made up 0.17% of Carson Advisory's portfolio in Q2 2026, its #118 holding.
Carson Advisory first reported a position in CVS Health in Q2 2023 and has held it in 11 quarters since.
Carson Advisory's CVS Health position peaked at $404K in Q1 2025.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Carson Advisory's 13F filing for Q2 2026, filed 11 Aug 2026.